Changeflow GovPing Pharma & Drug Safety USPTO Patent Grant: Allergy Treatment Compositions
Routine Notice Added Final

USPTO Patent Grant: Allergy Treatment Compositions

Favicon for changeflow.com USPTO Patent Grants - Therapeutics (A61P)
Published
Detected
Email

Summary

The USPTO has granted patent US12582679B2 to Vedanta Biosciences, Inc. for compositions and methods for treating allergy, including food allergy. The patent covers novel approaches to modulating immune responses and inducing immune tolerance or desensitization.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12582679B2 to Vedanta Biosciences, Inc. This patent, titled 'Compositions and methods for the treatment of allergy,' covers specific compositions and methods aimed at treating allergies, particularly food allergies. It also includes provisions for modulating immune responses associated with allergies and inducing immune tolerance or desensitization.

This patent grant is primarily an intellectual property matter and does not impose new regulatory obligations on companies. However, it signifies a new development in the therapeutic landscape for allergy treatments. Companies operating in the pharmaceutical and biotechnology sectors, particularly those involved in allergy research and development, should be aware of this granted patent as it may affect their own research, development, and commercialization strategies in this area.

Archived snapshot

Mar 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Compositions and methods for the treatment of allergy

Grant US12582679B2 Kind: B2 Mar 24, 2026

Assignee

Vedanta Biosciences, Inc.

Inventors

Rose L. Szabady, Bernat Olle, Bruce Roberts

Abstract

Provided herein are compositions and methods for the treatment of allergy, such as food allergy. Also provided herein are compositions and methods for modulating an immune response associated with allergy and/or inducing immune tolerance or desensitization to an allergy, such as a food allergy.

CPC Classifications

A61K 35/74 A61K 9/0053 A61K 9/19 A61K 9/48 A61K 31/00 A61K 35/741 A61K 9/0056 A61K 9/4866 A61P 37/08

Filing Date

2021-04-19

Application No.

17234158

Claims

19

View original document →

Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12582679B2

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Development Immunotherapy
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
R&D
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Medical Devices Public Health

Get alerts for this source

We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!